Hypertrophy of breast
Chapter 14:Diseases of the genitourinary system
ICD-10 N62 is a billable code used to indicate a diagnosis of hypertrophy of breast.
Hypertrophy of the breast, classified under ICD-10 code N62, refers to an abnormal enlargement of breast tissue that can occur in both males and females. This condition may arise due to various factors, including hormonal imbalances, genetic predisposition, or as a result of benign breast diseases such as fibrocystic changes or lipomas. Patients may present with symptoms such as breast lumps, nipple discharge, or discomfort, which can lead to further investigation through imaging studies like mammography or ultrasound. In some cases, hypertrophy can be associated with mastitis, an inflammatory condition of the breast, particularly in lactating women. The diagnosis of breast hypertrophy often requires a thorough clinical evaluation, including a physical examination and imaging, to rule out malignancy or other underlying conditions. Treatment options may vary from conservative management to surgical intervention, depending on the severity of symptoms and the impact on the patient's quality of life.
Detailed surgical notes, imaging results, and patient history.
Surgical intervention for symptomatic breast hypertrophy.
Ensure clear documentation of the rationale for surgery and any pre-operative assessments.
Hormonal assessment results and patient history regarding endocrine disorders.
Evaluation of hormonal imbalances contributing to breast hypertrophy.
Document any hormonal treatments or interventions that may affect breast tissue.
Performed for symptomatic breast hypertrophy.
Pre-operative assessment, surgical notes, and post-operative follow-up.
Breast surgeons should document the impact of hypertrophy on the patient's quality of life.
Breast hypertrophy can be caused by hormonal imbalances, genetic factors, or benign breast diseases. It is important to evaluate each patient individually to determine the underlying cause.
